Overview

 

Sermorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH 1-29), representing the biologically active portion of endogenous GHRH. Research has focused on its ability to stimulate natural growth hormone secretion, increase IGF-1 production, and influence metabolic, endocrine, and tissue-repair pathways. Due to its short half-life and preservation of physiologic feedback mechanisms, Sermorelin has been extensively studied as a model GHRH analog.

Mechanism of Action

Research suggests Sermorelin binds to Growth Hormone-Releasing Hormone receptors (GHRH-R) on pituitary somatotroph cells, stimulating pulsatile release of endogenous growth hormone. Subsequent increases in circulating IGF-1 may influence protein synthesis, tissue growth, metabolism, and cellular repair pathways. Unlike exogenous growth hormone, Sermorelin relies on the body’s natural endocrine regulation mechanisms.

Compound Information

Stability Information

Information provided for educational and research reference purposes only. Studies listed are third-party publications and do not constitute medical advice.